Notably, both CD9 levels and total EV protein concentrations were nearly equal among HCs, all CRC sample, and early-stage CRC specimens, indicating that fold-changes of the 13 targets were not influenced by the amount of EVs (Table 2 and Table S10, and Figure 5B,C). The gene discussed is CD9; the disease is colorectal carcinoma.